
    
      A phase I-II study of treatment of metastatic melanoma using induction therapy with
      Biochemotherapy (Temodar,Cisplatin, Velban,IL2 and IFN)plus Bevacizumab followed by
      consolidation therapy with Ipilimumab (BBI)
    
  